A Study of IBI351 in Healthy Subjects

NCT05688124 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: IBI351
DRUG: Esomeprazole

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.